Clopidogrel as adjunctive antiplatelet therapy during coronary stenting
- 14 December 1999
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 34 (7) , 1884-1890
- https://doi.org/10.1016/s0735-1097(99)00443-x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Incidence and Clinical Course of Thrombotic Thrombocytopenic Purpura Due to Ticlopidine Following Coronary StentingJAMA, 1999
- The Antiplatelet Effects of Ticlopidine and ClopidogrelAnnals of Internal Medicine, 1998
- Thrombotic Thrombocytopenic Purpura Associated with Ticlopidine: A Review of 60 CasesAnnals of Internal Medicine, 1998
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 1996
- Advances in Coronary AngioplastyNew England Journal of Medicine, 1996
- Antiplatelet therapyThe American Journal of Medicine, 1996
- Subacute stent thrombosis: Evolving issues and current conceptsJournal of the American College of Cardiology, 1996
- Novel Antithrombotic Drugs in DevelopmentDrugs, 1995
- A Comparison of Balloon-Expandable-Stent Implantation with Balloon Angioplasty in Patients with Coronary Artery DiseaseNew England Journal of Medicine, 1994
- A Randomized Comparison of Coronary-Stent Placement and Balloon Angioplasty in the Treatment of Coronary Artery DiseaseNew England Journal of Medicine, 1994